NRX Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.62-$5.05 |
Market Cap | $179.3M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $2.2M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $1.1M |
Diluted EPS | -$1.04 |
News
See moreYahoo Finance • 17 days ago
NRx Subsidiary HOPE Begins Patient Treatment Using AI-Guided TMS Systems
Yahoo Finance • 21 days ago
NRx Pharmaceuticals's NRX-101 Wins FDA Approval For Intermediate Population Expanded Access Protocol
Yahoo Finance • last month
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
Yahoo Finance • last month
NRx Announces Proposed Public Offering; Stock Down
About
CEO | Dr. Jonathan C. Javitt M.D., M.P.H. |
CFO | Mr. Michael S. Abrams M.B.A. |
Address | 1201 N. Market Street, Wilmington, DE, United States, 19801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |